Dye test helps spine surgeons see if They've cleaned enough
NCT ID NCT07363759
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested whether injecting a contrast dye into the disc space during TLIF spine surgery helps surgeons assess how well they have removed the disc. 56 patients having spinal fusion for degenerative spine disease were randomly assigned to either have the dye used as a check or as a guide to do more cleaning. The goal was to see if the dye improves the quality of disc space preparation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ISOVUE-300 contrast dye
- What this could lead to
- If successful, this technique could give surgeons real-time feedback to improve disc preparation during spinal fusion surgery.
- What could go wrong
- This is a small, completed trial with 56 patients. The dye is only used during surgery to guide the procedure, not to treat the underlying spine condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
56 people
The number who actually took part.
- Started
-
Apr 2019
- Finished
-
Jun 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients undergoing open circumferential transforaminal lumbar interbody fusion or midline cortical TLIF for degenerative spondylolisthesis Exclusion Criteria: * All not in the group above
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Degenerative spine are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Belly fat vs. body mass index: which better predicts spine surgery risks?
- New surgical approach aims to fix failed back fusions by restoring natural spinal curve
- Disc replacement may keep patients working longer than spinal fusion
- MRI may reveal who benefits most from physical therapy for back pain
- Spine surgeons test new CT technique to catch hidden instability during surgery
- New study tests drug-free pain relief after back surgery to cut opioid use